日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Are population-based patient-reported outcomes associated with overall survival in patients with advanced pancreatic cancer?

基于人群的患者报告结局与晚期胰腺癌患者的总生存期相关吗？

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.2704
Dai, Wei Fang; Beca, Jaclyn; Guo, Helen; Isaranawatchai, Wanrudee; Schwartz, Deborah; Naipaul, Rohini; Arias, Jessica; Qiao, Yao; Gavura, Scott; Redmond-Misner, Ruby; Ismail, Zahra; Barbera, Lisa; Chan, Kelvin
胰腺癌
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Real-world outcomes of FOLFIRINOX vs gemcitabine and nab-paclitaxel in advanced pancreatic cancer: A population-based propensity score-weighted analysis

FOLFIRINOX方案与吉西他滨联合白蛋白紫杉醇治疗晚期胰腺癌的真实世界疗效：一项基于人群倾向评分加权分析

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.2705
Chan, Kelvin K W; Guo, Helen; Cheng, Sierra; Beca, Jaclyn M; Redmond-Misner, Ruby; Isaranuwatchai, Wanrudee; Qiao, Lucy; Earle, Craig; Berry, Scott R; Biagi, James J; Welch, Stephen; Meyers, Brandon M; Mittmann, Nicole; Coburn, Natalie; Arias, Jessica; Schwartz, Deborah; Dai, Wei F; Gavura, Scott; McLeod, Robin; Kennedy, Erin D
胰腺癌
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Estimating the costs of intensity-modulated and 3-dimensional conformal radiotherapy in Ontario

估算安大略省调强放射治疗和三维适形放射治疗的成本

期刊:Current Oncology
影响因子:3.4
doi:10.3747/co.23.2998
Yong, J H E; McGowan, T; Redmond-Misner, R; Beca, J; Warde, P; Gutierrez, E; Hoch, J S
发表日期：2016
文献求助 收藏